GPRC5D and Miyoshi myopathy: GPRC5D expression was elevated in post-autologous stem cell transplantation (ASCT) (Fig. 4a, post ASCT, P = 0.003), which suggests that BsAb5003 is efficacious not only in early-line but also in late-line MM patients.